CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell TrialNirali N. Shah, Terry J. Fry, Staci Martin et al.|Journal of Clinical Oncology|2020Cited by 422
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CARHaneen Shalabi, Nirali N. Shah, Haiying Qin et al.|Blood|2022Cited by 179
Abstract CT051: Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with relapsed/refractory ALLHaneen Shalabi, Nirali N. Shah, Bonnie Yates et al.|Cancer Research|2020Cited by 8
Abstract LB-146: Phase I CD22 CAR T-cell trial updatesNirali N. Shah, Terry J. Fry, Haneen Shalabi et al.|Cancer Research|2019Cited by 4